Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$611K Sell
4,753
-85
-2% -$9.95K 0.27% 93
2026
Q1
$582K Sell
4,838
-9
-0.2% -$1.04K 0.28% 84
2025
Q4
$510K Sell
4,847
-176
-4% -$16.5K 0.25% 97
2025
Q3
$422K Sell
5,023
-225
-4% -$18.5K 0.21% 104
2025
Q2
$415K Sell
5,248
-304
-5% -$24.2K 0.21% 96
2025
Q1
$498K Buy
5,552
+472
+9% +$44.1K 0.28% 77
2024
Q4
$505K Sell
5,080
-418
-8% -$43.1K 0.5% 57
2024
Q3
$624K Buy
+5,498
New +$653K 0.62% 51

Other funds holding MRK

CWC Advisors's MRK Position: Q2 2026 in Review

CWC Advisors reduced its Merck (MRK) stake by 1.8% in Q2 2026, selling an estimated $9.95K and leaving 4,753 shares worth $611K. The position accounts for 0.27% of the portfolio, ranked #93.

CWC Advisors first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. The position peaked at $624K in Q3 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • CWC Advisors held 4,753 shares of Merck worth $611K as of Q2 2026.
  • CWC Advisors sold 85 Merck shares in Q2 2026, an estimated $9.95K.
  • Merck made up 0.27% of CWC Advisors's portfolio in Q2 2026, its #93 holding.
  • CWC Advisors first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • CWC Advisors's Merck position peaked at $624K in Q3 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CWC Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.